Press Release

According to a new market research study titled ‘Immunoassay Market to 2027 – Global Analysis and Forecasts by Test Type.’ The global Immunoassay Market is expected to reach US$ 37,987.8 Mn in 2027 from US$ 21,800.0 Mn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The report highlights the trends prevalent in the global immunoassay market and the factors driving the market along with those that act as deterrents to its growth.

Traditional in vitro diagnostics (IVDs) are generally conducted in laboratories prepared with expensive equipment and staffed with trained personnel accountable for performing the tests. Since the last few decades, diagnostic testing has gradually progressed out of the central laboratory and into testing sites, which is close to patients. The point-of-care testing (POCT) enables laboratory service providers to accomplish testing at the patient’s location, facilitating disease diagnosis, monitoring, and management. Intense technological inventions in POCT have been done during the last few years. For instance, nanotechnologies significantly enhance magnetic, electrical, optical, and chemical properties, liable for improving the performance of POCT. The latest trend in point-of-care diagnostics (POCD) is tending intensely to smart devices with mobile healthcare. It could genuinely transform healthcare monitoring and management, making a new way for next-generation POCT. Therefore, these factors have increased the demand of immunoassay-based point-of-care testing for diagnostic purposes in the coming future.

Get Sample PDF of this Report @

Global Immunoassay Market, based on technology, was segmented as, ELISA, Fluorescence, Chemiluminescence, Rapid Test, Western Blot, Enzyme-Linked Immune Absorbent Spot (ELISPOT), Polymerase Chain Reaction (PCR). The chemiluminescence segment led the market in 2018, and is expected to retain its dominance during the forecast period from 2019 to 2027 due to higher acceptance of the method for diagnosis purpose. Moreover, it has a much broader detection range than either RIAs or ELISAs and is also exceptionally sensitive under low analyte concentration conditions. The segment is also anticipated to witness growth at a significant rate during the forecast period, 2019 to 2027.

The major players operating in the Immunoassay Market are F. Hoffmann-La Roche Ltd., Abbott, bioMérieux SA, BD, Danaher Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Thermo Fisher Scientific Inc., Quidel Corporation and Siemens. Organic growth strategies such as product launches have helped companies to improve their position in the immunoassay market. For instance, in January 2019, Thermo Fisher Scientific launched a new complementary diagnostic immunoassay for measuring plazomicin concentrations, the Thermo Scientific QMS Plazomicin Immunoassay, is developed in collaboration with Achaogen. Plazomicin is a novel therapeutic antibiotic and aminoglycoside used to treat patients with complicated urinary tract infections.

Ask For Discount @


Global Immunoassay Market – By Product

  • Reagents & Kits
  • Analyzers & Instruments
    • Open-Ended Systems
    • Closed-Ended Systems
  • Software & Services

Global Immunoassay Market – By Technology

  • Enzyme-linked Immunosorbent Assays (ELISA)
  • Fluorescence
  • Chemiluminescence
  • Rapid Test
  • Western Blot
  • Enzyme-linked Immune Absorbent Spot (ELISPOT)
  • Polymerase Chain Reaction (PCR)

Global Immunoassay Market – By Application

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Other Applications

Global Immunoassay Market – By End User

  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical & Biotech Companies
  • Academic Research Centers
  • Others

Contact Us:

Call: +1-646-491-9876
Email: [email protected]

This post was originally published on The Picayune Current